Literature DB >> 28982804

Autoadjusted versus fixed CPAP for obstructive sleep apnoea: a multicentre, randomised equivalence trial.

Konrad E Bloch1,2, Fabienne Huber1, Michael Furian1, Tsogyal D Latshang1, Christian M Lo Cascio1, Yvonne Nussbaumer-Ochsner1, Oliver Senn3, Erich W Russi1,2, Malcolm Kohler1,2, Otto D Schoch4, Alexander Turk5, Edelbert Imhof6, Irène Laube6, Felix Matthews1, Robert Thurnheer7.   

Abstract

BACKGROUND: The obstructive sleep apnoea syndrome (OSAS) is conventionally treated by continuous positive airway pressure set at a fixed level (fCPAP). Automatic mask pressure adjustment (autoCPAP) is increasingly used during home therapy. We investigated whether autoCPAP is equivalent to fCPAP in improving sleepiness in patients with OSAS in the long-term.
METHODS: In this multicentre equivalence trial, 208 patients with OSAS, with median Epworth sleepiness score (ESS) 13, apnoea/hypopnoea index 48.4/hour, were randomised to treatment with autoCPAP (5-15 mbar) or fCPAP (pressure set at the 90th percentile applied by autoCPAP during 2-4 weeks adaptation). Coprimary outcomes were changes in subjective and objective sleepiness from baseline to 2 years after treatment. Equivalence ranges were ±2 points in ESS and ±3 min sleep resistance time evaluated by recording responses to light signals.
RESULTS: At 2 years, in the intention to treat analysis, the reduction in sleepiness versus pretreatment baseline was similar in patients using autoCPAP (n=113, mean ESS-change -6.3, 95% CI -7.1 to -5.5; sleep resistance time +8.3 min, +6.9 to +9.7) and fCPAP (n=95, mean ESS-change -6.2, 95% CI -7.0 to -5.3; sleep resistance time +6.3 min, +4.7 to +7.8). The 95% CI of difference in ESS-reduction between autoCPAP and fCPAP was -0.9 to +1.4 and the 95% CI of difference in increase in sleep resistance time was -2.6 to +1.0 min. Blood pressure reduction and OSAS-related costs were similar between groups.
CONCLUSIONS: AutoCPAP and fCPAP are equivalent within prespecified ranges in improving subjective and objective sleepiness in patients with OSAS over the course of 2 years. Costs of these treatments are similar. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT00280800. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  non invasive ventilation; sleep apnoea

Mesh:

Year:  2017        PMID: 28982804     DOI: 10.1136/thoraxjnl-2016-209699

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  7 in total

Review 1.  Current and novel treatment options for obstructive sleep apnoea.

Authors:  Winfried Randerath; Jan de Lange; Jan Hedner; Jean Pierre T F Ho; Marie Marklund; Sofia Schiza; Jörg Steier; Johan Verbraecken
Journal:  ERJ Open Res       Date:  2022-06-27

2.  Health Preference Measures in Patients with Obstructive Sleep Apnea Syndrome Undergoing Continuous Positive Airway Pressure Therapy: Data from a Randomized Trial.

Authors:  Fabienne L Huber; Michael Furian; Malcolm Kohler; Tsogyal D Latshang; Yvonne Nussbaumer-Ochsner; Alexander Turk; Otto D Schoch; Irene Laube; Robert Thurnheer; Konrad E Bloch
Journal:  Respiration       Date:  2021-02-04       Impact factor: 3.580

3.  Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial.

Authors:  Lu Tan; Tsogyal D Latshang; Sayaka S Aeschbacher; Fabienne Huber; Deborah Flueck; Mona Lichtblau; Stefanie Ulrich; Elisabeth D Hasler; Philipp M Scheiwiller; Silvia Ulrich; Konrad E Bloch; Michael Furian
Journal:  JAMA Netw Open       Date:  2020-06-01

4.  Reduction in sympathetic tone in patients with obstructive sleep apnoea: is fixed CPAP more effective than APAP? A randomised, parallel trial protocol.

Authors:  Erika Treptow; Jean Louis Pepin; Sebastien Bailly; Patrick Levy; Cecile Bosc; Marie Destors; Holger Woehrle; Renaud Tamisier
Journal:  BMJ Open       Date:  2019-04-04       Impact factor: 2.692

5.  Addition of bacterial filter alters positive airway pressure and non-invasive ventilation performances.

Authors:  Claudio Rabec; Emeline Fresnel; Yann Rétory; Kaixian Zhu; Karima Joly; Adrien Kerfourn; Benjamin Dudoignon; Alexis Mendoza; Antoine Cuvelier; Jean-François Muir; Boris Melloni; Jean-François Chabot; Jésus Gonzalez-Bermejo; Maxime Patout
Journal:  Eur Respir J       Date:  2022-04-14       Impact factor: 33.795

6.  Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.

Authors:  Barry Kennedy; Toby J Lasserson; Dariusz R Wozniak; Ian Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02

Review 7.  Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy.

Authors:  Jeremy R Tietjens; David Claman; Eric J Kezirian; Teresa De Marco; Armen Mirzayan; Bijan Sadroonri; Andrew N Goldberg; Carlin Long; Edward P Gerstenfeld; Yerem Yeghiazarians
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.